En Ben Su
Chief Executive Officer at GETEIN BIOTECH, INC
Net worth: 284 M $ as of 2024-04-29
Profile
En Ben Su is the founder of Getein Biotech, Inc. which was founded in 2002.
He held the title of Chairman & General Manager starting in 2014.
Currently, Dr. Su is the Chairman at Wuhan King Diagnostic Technology Co., Ltd.
since 2020 and Chairman at Jiangsu China Railway Arit New Materials Co., Ltd.
since 2018.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GETEIN BIOTECH, INC. CLASS A
43.23% | 2023-05-25 | 219,218,114 ( 43.23% ) | 284 M $ | 2024-04-29 |
En Ben Su active positions
Companies | Position | Start |
---|---|---|
GETEIN BIOTECH, INC | Chief Executive Officer | 2014-11-19 |
Jiangsu China Railway Arit New Materials Co., Ltd.
Jiangsu China Railway Arit New Materials Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Jiangsu China Railway Arit New Materials Co. Ltd. provides research and development services. The company is located in China. | Chairman | 2018-08-31 |
Wuhan King Diagnostic Technology Co., Ltd.
Wuhan King Diagnostic Technology Co., Ltd. Medical SpecialtiesHealth Technology Wuhan King Diagnostic Technology Co., Ltd. engages in the research and development of vitro diagnostic instruments and vitro diagnostic reagents. The company was founded by Quan Xin Ma on March 16, 2006 and is headquartered in Wuhan, China. | Chairman | 2020-08-27 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GETEIN BIOTECH, INC | Health Technology |
Health Technology |
Private companies | 1 |
---|---|
Jiangsu China Railway Arit New Materials Co., Ltd.
Jiangsu China Railway Arit New Materials Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Jiangsu China Railway Arit New Materials Co. Ltd. provides research and development services. The company is located in China. | Commercial Services |
- Stock Market
- Insiders
- En Ben Su